Use of chlorophyll derivatives to improve microcirculation disorder

A microcirculation disorder and chlorophyll technology, applied in the field of medicine, can solve the problems of easily causing stomach discomfort, limited users, obvious toxic and side effects, etc., and achieve the effects of preventing and improving microcirculation disorders, being safe for the population, and simple in process.

Active Publication Date: 2021-09-28
武汉联合药业有限责任公司
View PDF11 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, even if only for the treatment of specific parts, the efficacy of existing drugs also needs to be improved
Furthermore, the existing drugs not only have obvious toxic and side effects, but are likely to cause adverse reactions and side effects such as stomach discomfort, nausea, heartburn, loss of appetite, skin rashes, and bleeding, and the use of the drugs is limited, so it is not suitable or recommended for children and the elderly , pregnant women, lactating women take
In addition, existing medicines are often expensive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of chlorophyll derivatives to improve microcirculation disorder
  • Use of chlorophyll derivatives to improve microcirculation disorder
  • Use of chlorophyll derivatives to improve microcirculation disorder

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0070] Preparation of reference solution: Accurately weigh 0.143g of spectrally pure ferric oxide dried at 130°C to constant weight, put it in a beaker, add 5ml of hydrochloric acid solution (1→2) to dissolve, transfer to a 100ml measuring bottle, add Add 4ml of hydrochloric acid solution (1→2), add water to the mark, shake well, accurately measure 10ml, put it in a 100ml measuring bottle, add water to the mark, shake well to get a solution containing about 100μg of Fe per 1ml. Accurately measure 0, 0.2, 0.4, 0.6, 0.8 and 1.0ml of the above solutions respectively, put them in a 10ml measuring bottle, add nitric acid solution (1→500) to the mark, shake well, and you get it.

[0071] Preparation of the test solution: Take an appropriate amount of sample, grind it finely, accurately weigh 10mg, put it in a 50ml beaker, add 1.5ml of nitric acid, 3 drops of perchloric acid, cover with a watch glass, heat to nearly dry at 150-160°C, add Nitric acid (1→2) 2ml, cover with a watch glas...

Embodiment 1

[0105] Example 1 Protective effect of silkworm excrement extract on cerebral acute microcirculation disorder

[0106] According to the above-mentioned method, the iron chlorophyllin sodium iron chlorophyllin acid sodium weight percentage content is about 37.6%, and other chlorophyll derivatives are calculated as iron chlorophyllin (b) for more than 60.0% silkworm excrement. The role of the test, the results are as follows.

[0107] Table 1 Effect of silkworm excrement extract on the change rate of rabbit brain microcirculation

[0108]

[0109] Note: Compared with the negative control group: *: P<0.05, **: P<0.01

[0110] Table 1 shows that, compared with the negative control group, the blood perfusion (PU) and moving blood cell velocity (V) of the silkworm excrement high-dose extract group were significantly reduced (P<0.01), and the blood cells of the silkworm excrement high-dose extract group The rate of change of the degree of aggregation (CMBC) and the evaluation i...

Embodiment 2

[0111] Example 2 The protective effect of silkworm excrement extract on muscle acute microcirculation disturbance

[0112] According to the above-mentioned method, the iron chlorophyllin sodium weight percentage content is about 37.6%, and other chlorophyll derivatives are calculated as iron chlorophyllin (b) for more than 60.0% of the silkworm excrement, for its effect on rabbit muscle acute microcirculation disorder The role of the test, the results are as follows.

[0113] Table 2 Effect of silkworm excrement extract on the change rate of rabbit muscle microcirculation

[0114]

[0115] Note: Compared with the negative control group: *: P<0.05, **: P<0.01

[0116] Table 2 shows that, compared with the negative control group, the change rate of blood perfusion (PU) in the high and middle dose groups of silkworm excrement extract was significantly reduced (P<0.01); the degree of blood cell aggregation (CMBC) in the high dose silkworm excrement extract group The rate of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
relative humidityaaaaaaaaaa
Login to view more

Abstract

The invention belongs to the field of medicine, and relates to the use of chlorophyll derivatives for improving microcirculation disorders, in particular to the use of chlorophyll derivatives in preparing medicines for treating and / or preventing microcirculation disorders. The chlorophyll derivatives of the present invention, such as chlorophyll extracts and silkworm excrement extracts, have good curative effects on improving various parts and overall microcirculation disorders. The chlorophyll derivatives can also comprehensively prevent and improve the microcirculation disturbance of the whole and some parts through their functions in multiple links. Moreover, the toxic and side effects of the chlorophyll derivatives are improved, the applicable population is wide and safe, and can be applied to treat children, the elderly, pregnant women and lactating women. In addition, the preparation method of the chlorophyll derivative and the process applied to the preparation of medicine are relatively simple, and the cost is effectively controlled.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to the use of chlorophyll derivatives for improving microcirculation disorders, in particular to the use of chlorophyll derivatives in preparing medicines for treating and / or preventing microcirculation disorders. Background technique [0002] Microcirculation refers to the blood circulation in capillaries between arterioles and venules. It is the part of the cardiovascular system in direct contact with tissue cells. The basic function of microcirculation is to carry out metabolism and material exchange. It is an important part of blood circulation and can be called the "second heart" of the human body. During the evolution process, organ microvessels and their parenchymal cells form a closely coordinated and highly adaptive three-dimensional structure. For the convenience of research, the configuration of organ microvessels is usually classified into hairpin type, dendrite type, reticulum t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/409A61P7/00
CPCA61K31/409A61K35/64
Inventor 刘朝胜付雯刘敏吴瑜罗京余明森王根才周红晖袁建新徐发新
Owner 武汉联合药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap